Oral therapy admilparant slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) in a Phase 3 ...
Cold and flu season can be stressful with PF, so columnist Kylene Henderson plans ahead so her family can still enjoy the ...
Columnist Ann Reynoso pays tribute to a special respiratory therapist who guided her during her pulmonary rehabilitation ...
Columnist Sam Kirton's birthday prompts reflection on his IPF and transplant journey. Like Phil Collins, he says, "Take a look at me now." ...
Columnist Sam Kirton recalls some of the scariest moments since his IPF diagnosis, and invites readers to share their own experiences.
Computer-based analyses of CT scans may help predict disease progression and track treatment response among people with PPF, per trial data.
Besides medication that can help manage symptoms and slow the progression of pulmonary fibrosis (PF), there are other therapeutic strategies available that can help patients cope with the effects of ...
Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic ...
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to BMS-986278, Bristol Myers Squibb’s investigational therapy for progressive pulmonary fibrosis (PF).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results